Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Saturday, November 2, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Saturday, November 2, 2024 | Latest Paper
Subscribe Now

TRENDING:

Steven Globerman

FDA approval may spell trouble for Canadian patients

  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade

FDA approval may spell trouble for Canadian patients

Opinion | BY STEVEN GLOBERMAN | January 10, 2024
  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in

FDA approval may spell trouble for Canadian patients

Opinion | BY STEVEN GLOBERMAN | January 10, 2024
  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade

FDA approval may spell trouble for Canadian patients

  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade

FDA approval may spell trouble for Canadian patients

Opinion | BY STEVEN GLOBERMAN | January 10, 2024
  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in

FDA approval may spell trouble for Canadian patients

Opinion | BY STEVEN GLOBERMAN | January 10, 2024
  • The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade

Ottawa should refocus on Canada’s largest trading partner

  • Despite a push to boost trade with Asian and European Union countries, the importance of America in Canada’s international trade has barely changed over
Opinion | BY STEVEN GLOBERMAN | October 16, 2023
United States Trade Representative Katherine Tai, left, and International Trade Minister Mary Ng hold a joint press conference in Ottawa on May 5, 2022. Among the reasons for focusing on our southern neighbour, the potential market in the U.S. for Canadian services exports dwarfs those in Indo-Pacific countries, writes Steven Globerman. The Hill Times photograph by Andrew Meade

Ottawa should refocus on Canada’s largest trading partner

Opinion | BY STEVEN GLOBERMAN | October 16, 2023
  • Despite a push to boost trade with Asian and European Union countries, the importance of America in Canada’s international trade has barely changed over

Ottawa should refocus on Canada’s largest trading partner

Opinion | BY STEVEN GLOBERMAN | October 16, 2023
  • Despite a push to boost trade with Asian and European Union countries, the importance of America in Canada’s international trade has barely changed over
United States Trade Representative Katherine Tai, left, and International Trade Minister Mary Ng hold a joint press conference in Ottawa on May 5, 2022. Among the reasons for focusing on our southern neighbour, the potential market in the U.S. for Canadian services exports dwarfs those in Indo-Pacific countries, writes Steven Globerman. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu